• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ethinylestradiol
    19 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    Diane 35
    Bayer
    RX
    full basket chart
    Multiple ingredients
    Diane 35

    Anti-Androgen. Cyproterone 2 mg, Ethinylestradiol 0.35 mg.
    COATED TABS: 21. 1 tab. dly. for 21 days,
    starting 1st day of menstrual cycle.
    See lit.
    Signs of androgenization in women:
    Pronounced forms acne, androgenat.
    alopecia, mild forms hirsutism.

    Emily
    Abic
    RX
    full basket chart
    Multiple ingredients
    Emily

    Estrogen, Progestogen. Ethinylestradiol 0.02 mg, Gestodene 0.075 mg.
    TABS: 1 x 21, 3 x 21. 1 tab dly. See lit.
    Oral contracept.

    Estelle-35
    Taro
    RX
    full basket chart
    Multiple ingredients
    Estelle-35

    Anti-Androgen, Estrogen. Cyproterone (acetate) 2 mg, Ethinylestradiol 0.035 mg.
    TABS: 21, 3 x 21. 1 tab. dly. for 21 days,
    starting 1st day of menstrual cycle.
    Signs of androgenization in women.
    pronounced forms of acne, androgenic
    alopecia and mild forms of hirsutism.
    C/I: Hypersens.; Concomit. use
    hormone. contracept.; Preg., Possible
    pregn., lact.; Present/hist. of breast.
    canc.; Thrombosis.; Present/hist. of lower extremet. thrombos.; Present/hist,
    of pulmon. embol.; Cardiac. dis. (e.g.,
    ang. pect., TIA).; Present/ histor. MI
    attack or stroke.; Chron. condit. that
    affect blood vessels (e.g diabetes).;
    Hyperlipidemia, hypertens., migraine
    with aura.; Present/hist. of hepat. dis.;
    Hepat. tumors.

    Evra
    Janssen
    RX
    not in the basket chart
    Multiple ingredients
    Evra

    Estrogen, Progestogen. Ethinylestradiol 0.6 mg, Norelgestromin 6 mg.
    TRANSDERMAL PATCHES: 3,9. 1st patch on
    day 1 of cycle. 1 patch (on same day)/
    wk. on day 8 and 15 of cycle. 4th wk
    (from day 22) is patch free. New cycle
    aft. 7 days patch free. See lit.
    Oral contracept. women 18-45 yrs.

    Feminet
    Dexcel
    RX
    full basket chart
    Multiple ingredients
    Feminet

    Estrogen, Progestogen. Desogestrel 0.15 mg, Ethinylestradiol 0.02 mg.
    TABS. : 1,3,4 (pack) × 21. 1 tab. dly. for 21
    days, start. on 1st day of cycle. See lit.
    Oral contracep.
    C/I: Hypersens. Presence/ hist. of VTE,
    DVTor pulmon. embol. Known hereditary
    / acquired predispose. for venous
    thromboembol., such as protein C defic.,
    protein S defic., antithrombin-III-defic. or
    APC-resistance, (include. Fact. V Leiden).,
    major surgery with prolon. immobil. Past
    heart attack, stroke; Present/ past ang.
    pect., TIA, high risk of art.
    thromboembol. due to Diabetes mell.
    with vasc. dis., hypertens.,
    antiphospholipid-antibod.
    (hypercholesterolem./
    hypertriglyceridaem.);
    hyperhomocysteinaem; Present/ past
    migraine with focal neurology. sympt..
    Jaundice /present/ past severe hep. dis.
    as long as liver funct.values have not
    returned to normal. Present/ hist. of liver
    tumor. Past/present or suspect. estrogen or progestin depend. cancer (e.g.: certain
    breast cancer, ovar., endomet., genitals).
    Undiagnosed vag. bleed. Known/
    suspected pregn., See lit.

    Flame
    Dexcel
    RX
    full basket chart
    Multiple ingredients
    Flame

    Estrogen, Progestogen. Ethinylestradiol 0.02 mg, Gestodene 0.075 mg.
    TABS: 1×21, 3×21. 1 tab dly. See lit.
    Oral contracept.
    C/I: Known hypersensitivity; known/
    suspected pregnancy, breastfeeding;
    undiagnosed abnormal vaginal
    bleeding; pancreatitis associated with
    hypercholesterolemia /
    hypertriglyceridaemia; diabetes with
    vascular disease; uncontrolled
    hypertension; migraine with focal
    neurological symptoms/aura; liver
    tumor/liver disease with liver function
    not returned to normal; present/
    suspected breast cancer; endometrial,
    cervical, vaginal cancer; present/past
    heart disease, angina, heart attack,
    stroke; deep vein thrombosis,
    pulmonary embolism, retina artery
    occlusion; condition or family history
    increases risk for VTE/ATE. See lit.

    CLOSE